Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Drain fluid's pH predicts anastomotic leak in colorectal surgery results of a prospective analysis of 173 patients.

Molinari E, Giuliani T, Andrianello S, Talamini A, Tollini F, Tedesco P, Pirani P, Panzeri F, Sandrini R, Remo A, Laterza E.

Minerva Chir. 2019 Sep 30. doi: 10.23736/S0026-4733.19.08018-0. [Epub ahead of print]

PMID:
31580043
2.

Immune Resistance and EGFR Antagonists in Colorectal Cancer.

Giordano G, Remo A, Porras A, Pancione M.

Cancers (Basel). 2019 Jul 31;11(8). pii: E1089. doi: 10.3390/cancers11081089. Review.

3.

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes.

Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafà R, Giordano G, Pancione M, Grillo F, Mastracci L.

Cancers (Basel). 2019 Jul 23;11(7). pii: E1036. doi: 10.3390/cancers11071036. Review.

4.

Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions.

Crinò SF, Bernardoni L, Brozzi L, Barresi L, Malleo G, Salvia R, Frulloni L, Sina S, Parisi A, Remo A, Larghi A, Gabbrielli A, Manfrin E.

Gastrointest Endosc. 2019 Dec;90(6):933-943. doi: 10.1016/j.gie.2019.05.009. Epub 2019 May 14.

PMID:
31100310
5.

Pseudo solid-appearing pancreatic serous microcystic adenomas: Histologic diagnosis with the EUS core biopsy fork-tip needle.

Manfrin E, Perini C, Di Stefano S, Bernardoni L, Parisi A, Frulloni L, Sina S, Remo A, Gabbrielli A, Crinò SF.

Endosc Ultrasound. 2019 Sep-Oct;8(5):334-341. doi: 10.4103/eus.eus_11_19.

6.

CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy.

Remo A, Cecchini MP, Benati D, Bernardi P, Manfrin E, Giordano G, Bonomi F, Parcesepe P, Fassan M, Colombari R, Sbarbati A, Pancione M.

Virchows Arch. 2019 Aug;475(2):245-249. doi: 10.1007/s00428-019-02554-4. Epub 2019 Mar 10.

PMID:
30852641
7.

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer.

Giordano G, Parcesepe P, D'Andrea MR, Coppola L, Di Raimo T, Remo A, Manfrin E, Fiorini C, Scarpa A, Amoreo CA, Conciatori F, Milella M, Caruso FP, Cerulo L, Porras A, Pancione M.

J Exp Clin Cancer Res. 2019 Jan 22;38(1):28. doi: 10.1186/s13046-018-1019-5.

8.

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches.

Parente P, Parcesepe P, Covelli C, Olivieri N, Remo A, Pancione M, Latiano TP, Graziano P, Maiello E, Giordano G.

Gastroenterol Res Pract. 2018 Dec 18;2018:7530619. doi: 10.1155/2018/7530619. eCollection 2018. Review.

9.

Urothelial bladder carcinoma metastasizing to the eye: A systematic review and case report.

Giordano G, Olivieri N, D'Andrea MR, Di Raimo T, Manfrin E, Remo A, Pancione M, Brunelli M, De Santis E, Coppola G, Scarpa A, Coppola L, Parcesepe P.

Oncol Lett. 2019 Jan;17(1):462-467. doi: 10.3892/ol.2018.9579. Epub 2018 Oct 15.

10.

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.

Parcesepe P, Giordano G, Zanella C, Giuliani J, Greco F, Bonetti A, Pancione M, Manfrin E, Molinari E, Latiano TP, D'Andrea MR, Fassan M, Olivieri N, Remo A.

Pathol Res Pract. 2019 Feb;215(2):387-391. doi: 10.1016/j.prp.2018.11.021. Epub 2018 Nov 29.

PMID:
30553605
11.

Clear cell dysplasia in a sessile serrated adenoma.

Fassan M, Pennelli G, Mastracci L, Remo A, Cappellesso R, Lo Mele M, Realdon S, Munari G, Lazzi S, Rugge M.

Pathol Res Pract. 2018 Dec;214(12):2121-2122. doi: 10.1016/j.prp.2018.09.020. Epub 2018 Sep 28. No abstract available.

PMID:
30293952
12.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

13.

MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.

Saraggi D, Galuppini F, Fanelli GN, Remo A, Urso EDL, Bao RQ, Bacchin D, Guzzardo V, Luchini C, Braconi C, Farinati F, Rugge M, Fassan M.

Pathol Res Pract. 2018 Jun;214(6):835-839. doi: 10.1016/j.prp.2018.04.018. Epub 2018 May 1.

PMID:
29731265
14.

t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.

Caliò A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, Zampini C, Argani P, Martignoni G.

Mod Pathol. 2018 Mar;31(3):474-487. doi: 10.1038/modpathol.2017.144. Epub 2017 Oct 20.

15.

PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.

Saraggi D, Galuppini F, Remo A, Urso EDL, Bacchin D, Salmaso R, Lanza C, Bao RQ, Fanelli GN, Guzzardo V, Luchini C, Scarpa M, Farinati F, Fassan M, Rugge M.

Histopathology. 2017 Sep;71(3):470-474. doi: 10.1111/his.13254. Epub 2017 Jun 29.

PMID:
28502094
16.

Clear cell colorectal carcinoma: Time to clarify diagnosis.

Remo A, Grillo F, Mastracci L, Fassan M, Sina S, Zanella C, Parcesepe P, Damiano Urso E, Pancione M, Bortuzzo G, Scarpa A, Manfrin E.

Pathol Res Pract. 2017 May;213(5):447-452. doi: 10.1016/j.prp.2017.02.013. Epub 2017 Feb 24. Review.

PMID:
28285963
17.

Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal.

Remo A, Fassan M, Lanza G.

Pathologica. 2016 Sep;108(3):104-109. Review.

PMID:
28195261
19.

Usefulness of breast cytology after lipofilling.

Ficial M, Parisi A, Remo A, Vasori S, Manfrin E.

Pathology. 2016 Dec;48(7):746-747. doi: 10.1016/j.pathol.2016.07.012. Epub 2016 Oct 22. No abstract available.

PMID:
27780600
20.

Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.

Votino C, Laudanna C, Parcesepe P, Giordano G, Remo A, Manfrin E, Pancione M.

J Gastroenterol. 2017 Mar;52(3):327-340. doi: 10.1007/s00535-016-1222-0. Epub 2016 May 11.

PMID:
27169843
21.

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

Parcesepe P, Sina S, Zanella C, Pancione M, Giuliani J, Detogni P, Curti P, Bonetti A, Manfrin E, Remo A.

Int J Surg Pathol. 2016 Aug;24(5):443-7. doi: 10.1177/1066896916628279. Epub 2016 Feb 12. Review.

PMID:
26873338
22.

Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease.

Luchini C, Parcesepe P, Mafficini A, Nottegar A, Parolini C, Veronese N, Remo A, Manfrin E.

Placenta. 2015 Nov;36(11):1318-24. doi: 10.1016/j.placenta.2015.09.012. Epub 2015 Oct 10.

PMID:
26459371
23.

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

Giordano G, Febbraro A, Tomaselli E, Sarnicola ML, Parcesepe P, Parente D, Forte N, Fabozzi A, Remo A, Bonetti A, Manfrin E, Ghasemi S, Ceccarelli M, Cerulo L, Bazzoni F, Pancione M.

J Exp Clin Cancer Res. 2015 Oct 1;34:108. doi: 10.1186/s13046-015-0225-7.

24.

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

Giuliani J, Martelli S, Remo A, Bonetti A.

Tumori. 2015 Jul 24;101(4):e115-7. doi: 10.5301/tj.5000317.

PMID:
25953440
25.

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.

Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, Bensmail H, Birnbaum D, Van Laere SJ, Colantuoni V, Bonetti F, Bertucci F, Manfrin E, Ceccarelli M.

J Transl Med. 2015 May 1;13:138. doi: 10.1186/s12967-015-0492-2.

26.

CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications.

Luchini C, Parcesepe P, Nottegar A, Parolini C, Mafficini A, Remo A, Chilosi M, Manfrin E.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):215-20. doi: 10.1097/PAI.0000000000000175.

PMID:
25906120
27.

p16 Expression in Prostate Cancer and Nonmalignant Lesions: Novel Findings and Review of the Literature.

Remo A, Pancione M, Zanella C, Manfrin E.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):201-6. doi: 10.1097/PAI.0000000000000171. Review.

PMID:
25906117
28.

Subglotic malt-lymphoma of the larynx: an unusual presentation of chronic cough.

Zapparoli M, Trolese AR, Remo A, Sina S, Bonetti A, Micheletto C.

Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):461-5.

PMID:
25280040
29.

Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.

Giordano G, Febbraro A, Venditti M, Campidoglio S, Olivieri N, Raieta K, Parcesepe P, Imbriani GC, Remo A, Pancione M.

Gastroenterol Res Pract. 2014;2014:526178. doi: 10.1155/2014/526178. Epub 2014 Jul 21. Review.

30.

Comparison between invasive breast cancer with extensive peritumoral vascular invasion and inflammatory breast carcinoma: a clinicopathologic study of 161 cases.

Manfrin E, Remo A, Pancione M, Cannizzaro C, Falsirollo F, Pollini GP, Pellini F, Molino A, Brunelli M, Vendraminelli R, Ceccarelli M, Pagnotta SM, Simeone I, Bonetti F.

Am J Clin Pathol. 2014 Sep;142(3):299-306. doi: 10.1309/AJCPOXKX67KRAOVM.

PMID:
25125618
31.

KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.

Battaglia P, Baritono E, Remo A, Vendraminelli R, Conti A.

Tumori. 2014 Mar-Apr;100(2):122-7. doi: 10.1700/1491.16391.

PMID:
24852854
32.

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis.

Pancione M, Giordano G, Remo A, Febbraro A, Sabatino L, Manfrin E, Ceccarelli M, Colantuoni V.

J Immunol Res. 2014;2014:686879. doi: 10.1155/2014/686879. Epub 2014 Jan 16. Review.

33.

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

Pancione M, Remo A, Zanella C, Sabatino L, Di Blasi A, Laudanna C, Astati L, Rocco M, Bifano D, Piacentini P, Pavan L, Purgato A, Greco F, Talamini A, Bonetti A, Ceccarelli M, Vendraminelli R, Manfrin E, Colantuoni V.

J Transl Med. 2013 Nov 28;11:297. doi: 10.1186/1479-5876-11-297.

34.

Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.

Pagnotta SM, Laudanna C, Pancione M, Sabatino L, Votino C, Remo A, Cerulo L, Zoppoli P, Manfrin E, Colantuoni V, Ceccarelli M.

PLoS One. 2013 Aug 19;8(8):e72638. doi: 10.1371/journal.pone.0072638. eCollection 2013.

35.

Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management.

Remo A, Zanella C, Pancione M, Astati L, Piacentini P, Cingarlini S, Bonetti A, Micheletto C, Talamini A, Chilosi M, Vendraminelli R, Manfrin E.

Pathologica. 2013 Apr;105(2):69-72.

PMID:
23946985
36.

Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist.

Remo A, Pancione M, Zanella C, Vendraminelli R.

Pathologica. 2012 Dec;104(6):432-41. Review.

PMID:
23547429
37.

Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.

Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, Molinari E, Normanno N, Manfrin E, Vendraminelli R, Colantuoni V.

Diagn Pathol. 2013 Feb 20;8:31. doi: 10.1186/1746-1596-8-31.

38.

Genetic and epigenetic events generate multiple pathways in colorectal cancer progression.

Pancione M, Remo A, Colantuoni V.

Patholog Res Int. 2012;2012:509348. doi: 10.1155/2012/509348. Epub 2012 Jul 24.

39.

Intra-operative frozen section technique for breast cancer: end of an era.

Manfrin E, Remo A, Falsirollo F, Pollini GP, Parisi A, Nottegar A, Bonetti F.

Pathologica. 2011 Dec;103(6):325-30.

PMID:
22558889
40.

Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature.

Remo A, Zanella C, Molinari E, Talamini A, Tollini F, Piacentini P, Battaglia P, Baritono E, Bonetti A, Lanza F, Fasolin A, Manfrin E, Vendraminelli R.

Int J Surg Pathol. 2012 Apr;20(2):185-90. doi: 10.1177/1066896911415405. Epub 2011 Jul 26. Review.

PMID:
21791485
41.

Cancer size, histotype, and cellular grade may limit the success of fine-needle aspiration cytology for screen-detected breast carcinoma.

Manfrin E, Falsirollo F, Remo A, Reghellin D, Mariotto R, Dalfior D, Piazzola E, Bonetti F.

Cancer. 2009 Dec 25;117(6):491-9. doi: 10.1002/cncy.20053.

42.

Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.

Brunelli M, Manfrin E, Miller K, Eccher A, Gobbo S, Reghellin D, Chilosi M, Remo A, Martignoni G, Menestrina F, Bonetti F.

J Cutan Pathol. 2009 Jun;36(6):702-5. doi: 10.1111/j.1600-0560.2008.01114.x. Review.

PMID:
19515052
43.

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

Brunelli M, Manfrin E, Martignoni G, Miller K, Remo A, Reghellin D, Bersani S, Gobbo S, Eccher A, Chilosi M, Bonetti F.

Am J Clin Pathol. 2009 May;131(5):678-82. doi: 10.1309/AJCP09VUTZWZXBMJ.

PMID:
19369627
44.

Heightened resting neural activity predicts exaggerated stressor-evoked blood pressure reactivity.

Gianaros PJ, Sheu LK, Remo AM, Christie IC, Crtichley HD, Wang J.

Hypertension. 2009 May;53(5):819-25. doi: 10.1161/HYPERTENSIONAHA.108.126227. Epub 2009 Mar 9.

45.

Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).

Manfrin E, Mariotto R, Remo A, Reghellin D, Falsirollo F, Dalfior D, Bricolo P, Piazzola E, Bonetti F.

Cancer. 2009 Feb 1;115(3):499-507. doi: 10.1002/cncr.24038.

46.

Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.

Fiorio E, Mercanti A, Terrasi M, Micciolo R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti F, Giordano A, Cetto GL, Surmacz E.

BMC Cancer. 2008 Oct 22;8:305. doi: 10.1186/1471-2407-8-305.

47.

HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy.

Brunelli M, Manfrin E, Martignoni G, Bersani S, Remo A, Reghellin D, Chilosi M, Bonetti F.

Am J Clin Pathol. 2008 Jun;129(6):907-11. doi: 10.1309/MD79CDXN1D01E862.

PMID:
18480007
48.

Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience of the Verona Mammographic Breast Cancer Screening Program with real-time integrated radiopathologic activity (1999-2004).

Manfrin E, Mariotto R, Remo A, Reghellin D, Dalfior D, Falsirollo F, Bonetti F.

Cancer. 2008 Apr 25;114(2):74-82. doi: 10.1002/cncr.23412. No abstract available.

49.

Expression of aromatase and estrogen receptors in human adrenocortical tumors.

Barzon L, Masi G, Pacenti M, Trevisan M, Fallo F, Remo A, Martignoni G, Montanaro D, Pezzi V, Palù G.

Virchows Arch. 2008 Feb;452(2):181-91. Epub 2007 Dec 21.

PMID:
18157729
50.

Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.

Arnold RS, He J, Remo A, Ritsick D, Yin-Goen Q, Lambeth JD, Datta MW, Young AN, Petros JA.

Am J Pathol. 2007 Dec;171(6):2021-32. Epub 2007 Nov 30.

Supplemental Content

Support Center